A special scan being tested for breast cancer that spread to the brain
Original title: Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a late stage study in people, and it uses a scan rather than a new drug.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests an extra brain scan in people with ER positive breast cancer.
Who this trial is for. This trial is for people with ER positive breast cancer that spread to the brain. It tests an extra scan, called 18F-FES PET/CT, before planned radiation.
Where it stands. The trial has not reported results. The team is trying to find the best way to do this scan. People get checkups and MRI scans for 12 months.
What this means, and what it doesn't
What it could mean: Someone who fits this picture could ask their care team about the trial. Taking part would add one scan before radiation treatment.
What it doesn't mean: This does not mean the scan is proven to help. A trial is a test, not care your doctor can give you. Being in a trial is no promise that it will help you. It is not a cure.
Source: ClinicalTrials.gov, October 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.